Cytokines and metabolic regulation: A framework of bidirectional influences affecting Leishmania infection-Reference-Cited by-同舟云学术

Cytokines and metabolic regulation: A framework of bidirectional influences affecting Leishmania infection

Published:2021-11 Issue: Volume:147 Page:155267
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Bodhale Neelam,Ohms Mareike,Ferreira Carolina,Mesquita Inês,Mukherjee Arkajyoti,André Sónia,Sarkar Arup^ORCID,Estaquier Jérôme,Laskay Tamás,Saha Bhaskar^ORCID,Silvestre Ricardo^ORCID

Funder

European Society of Clinical Microbiology and Infectious Diseases

Canada Research Chairs

Fondation pour la Recherche Médicale

Fundação para a Ciência e a Tecnologia

Bundesministerium für Bildung und Forschung

Department of Biotechnology, Ministry of Science and Technology, India

Agence Nationale de la Recherche

European Regional Development Fund

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference220 articles.

1. Leishmaniasis. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis.

2. Chemotherapy of leishmaniasis: Present challenges;Uliana;Parasitology,2018

3. Immunometabolism governs dendritic cell and macrophage function;O’Neill;J. Exp. Med.,2016

4. Using metabolomics to dissect host–parasite interactions;Kloehn;Curr. Opin. Microbiol.,2016

5. Metabolic reprogramming in macrophages and dendritic cells in innate immunity;Kelly;Cell Res.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles;Frontiers in Immunology;2024-08-15

2. Natural endoperoxides as promising anti-leishmanials;Phytomedicine;2024-07

3. In silico and in vitro potentials of crocin and amphotericin B on Leishmania major: Multiple synergistic mechanisms of actions;PLOS ONE;2023-09-08

4. Intramacrophage lipid accumulation compromises T cell responses and is associated with impaired drug therapy against visceral leishmaniasis;Immunology;2023-08-27

5. Krebs cycle enzymes for targeted therapeutics and immunotherapy for anti-leishmanial drug development using: Pathways, potential targets, and future perspectives;Life Sciences;2023-06